
Biocidal Product License and ÜTS: The Medical Device Boundary
Biocidal products are not registered in ÜTS; the license is obtained from HSGM. Device disinfectants are subject to the medical device legislation. The boundary between medical devices and biocides, and ÜTS registration.
You have a disinfectant in hand. Your supplier says "it has a CE certificate", the institution that opened the tender wants an ÜTS registration, and someone else asks for the product's biocidal licence. All three cannot be right: the same product is not placed on the market under both medical device legislation and biocidal product legislation. A product belongs to one side, and that side is determined not by the product's chemical content but by the intended purpose declared by its manufacturer.
This page draws that line. It explains when a product is regarded as a medical device, which disinfection products definitely stay on the medical device side, how the decision is made for borderline products, and what consequences follow from registering on the wrong side.
A warning about sources is needed first. Every provision on the medical device side is given here with its article number; the sources are the Medical Device Regulation (Tıbbi Cihaz Yönetmeliği) published in the Official Gazette No. 31499 (bis) of 2/6/2021 and the Manual on Registration Procedures of Medical Devices in the Product Tracking System (Tıbbi Cihazların Ürün Takip Sistemine Kayıt Süreçlerine İlişkin Kılavuz). The biocidal side is regulated by a separate regulation and the process is run by a separate authority; we do not repeat the article-level provisions of that legislation on this page, because the medical device side of the boundary is our field of expertise. For the biocidal application process itself, you need to apply to the competent unit.
ÜTS is not a registration place for biocidal products
The answer to this question is written explicitly in the Manual and is repeated in three places. Article 27(7)(dd)(5) of the Manual states that, without prejudice to the registration procedures of biocidal products or cosmetic products, only the registration of medical devices, in vitro diagnostic devices and parts defined as medical device accessories or in vitro diagnostic device accessories, which fall under the definition of "Device" as referred to in Article 4 of the Manual and are within the scope of the Medical Device Regulations, is carried out in ÜTS. The same provision appears in identical wording in Article 25(7)(z)(5) of the Manual for the old regulations and in Article 30(7)(aa)(4) for the IVDR.
The phrase "without prejudice" is the key word here: the two registration regimes are not alternatives to each other, they are independent of each other. That ÜTS does not register biocidal products does not mean those products are unregistered; it means they are registered somewhere else.
The definition accepted by ÜTS is also narrow. Article 4(1)(f) of the Manual defines "Device" as a medical device, medical device accessory, in vitro diagnostic device, in vitro diagnostic device accessory, or a product listed in Annex XVI of the MDR, called a "device" under the New Medical Device Regulations or the Old Medical Device Regulations. For a product that does not fall within this definition, there is no correct registration route in ÜTS.
Where the medical device definition ends
The whole boundary debate starts in one definition article. Article 3(1)(eee)(1) of the Medical Device Regulation defines a medical device as an instrument, apparatus, equipment, software, implant, reagent, material or other article intended by the manufacturer to be used on humans, whose principal intended function is not achieved in or on the human body by pharmacological, immunological or metabolic means, but which may be assisted in its function by such means, and which is designed specifically for one or more of certain medical purposes. Sub-points (i) to (iv) of the same sub-paragraph list these medical purposes as diagnosis, prevention, monitoring, prediction, prognosis, treatment or alleviation of disease; diagnosis, monitoring, treatment, alleviation of, or compensation for, an injury or disability; investigation, replacement or modification of the anatomy or of a physiological or pathological process or state; and providing information by means of in vitro examination of specimens derived from the human body.
Sub-paragraph (2) of the same point also includes devices for the control or support of conception in the definition. So "medical device" is not a product category but an intended-purpose test. If the product passes this test it is a device; if it does not, it is not a device, whatever it contains.
The intended purpose is also defined. Article 3(1)(hh) of the same Regulation defines it as the use for which a device is intended according to the data supplied by the manufacturer on the label, in the instructions for use or in promotional or sales materials or statements, and as specified by the manufacturer in the clinical evaluation. The manufacturer determines and documents the intended purpose; the importer or seller cannot reinterpret it afterwards.
Products that disinfect devices are on the medical device side
This is the clearest of the borderline cases, and the answer is written in the definition itself. Article 3(1)(eee)(3) of the Medical Device Regulation also includes in the medical device definition products specifically intended for the cleaning, disinfection or sterilisation of the devices referred to in Article 1(2) and of the devices referred to in sub-paragraph (1) of the same point. Article 1(2) of the same Regulation states that medical devices, medical device accessories and the products listed in Annex XVI will hereafter be called "devices".
Read this way, the picture is as follows: if a disinfectant is specifically designed for the cleaning, disinfection or sterilisation of medical devices, that product is itself a medical device. The product may be a liquid, a powder or a washing solution; it does not change the result.
Classification follows from this. Section 7.3 of Annex VIII of the Regulation (Rule 16) states that all devices intended specifically to be used for disinfecting or sterilising medical devices are classified as class IIa, but that devices which are disinfecting solutions or washer-disinfectants intended specifically to be used for disinfecting invasive devices, as the end point of processing, are classified as class IIb. The same rule places all devices intended to be used for disinfecting, cleaning, rinsing or, where appropriate, hydrating contact lenses in class IIb.
The last sentence of the same rule sets an exception that is often overlooked in practice: this rule does not apply to devices intended to clean devices other than contact lenses by means of physical action only. So a product for mechanical cleaning and a product for disinfection are not under the same rule.
The Regulation's list of exclusions does not name biocidal products
A detail needing attention here. Article 1(4) of the Medical Device Regulation lists, point by point, the products to which the Regulation does not apply: point (a) in vitro diagnostic devices, point (b) medicinal products, point (c) advanced therapy medicinal products, point (ç) human blood and blood products, point (d) products covered by the Cosmetics Regulation published in the Official Gazette No. 25823 of 23/5/2005, points (e) and (f) tissues and cells of animal and human origin, point (g) products containing viable biological material, and point (ğ) food.
Biocidal products are not in this list. There is an explicit exclusion for cosmetics but none for biocidal products; so the boundary is drawn not by an explicit exclusion provision but by the definition itself. That a product is biocidal does not by itself show that it is outside the scope of the Medical Device Regulation; the product must fall outside the medical device definition in Article 3.
In practice this distinction means the following: the sentence "this product is biocidal, so it cannot be a medical device" is not a justification. The justification is to show that the product's intended purpose corresponds to none of the medical purposes in the definition.
Who decides for borderline products
The Regulation foresees this possibility and sets out a route. Article 4(1) of the Medical Device Regulation states that the Agency will, where necessary, submit a duly substantiated request to the Commission in order to determine whether a specific product, or a category or group of products, falls within the definition of "medical device" or "medical device accessory", or in order to clarify the regulatory status of products that are borderline between medicinal products, human tissues and cells, cosmetic products, biocidal products or food products and medical devices. Paragraph 2 of the same article states that the Agency will share expertise, within the scope of products in its own field of duty, in order to ensure that the legislation applicable to a product or category of products is determined.
This provision says two things at once. First, the boundary between biocidal products and medical devices is recognised by the legislation itself as a problem; it is not a doubt that you invented. Second, the firm does not finally determine this boundary; the competent authority does. The firm does the best it can: it states the intended purpose clearly, files its reasoning, and, where there is doubt, uses the route that asks for a decision.
What determines the boundary is the declared intended purpose, not the formulation
Two products containing the same active substance can fall on different sides. The reason is the definition of intended purpose in Article 3(1)(hh) of the Regulation: the intended purpose is what the manufacturer says on the label, in the instructions for use and in the promotional materials.
This does not leave the declaration free; on the contrary, it creates strict responsibility. Article 7(1) of the same Regulation prohibits the use, in the labelling, instructions for use, making available on the market, putting into service and advertising and promotion of devices, of text, names, trademarks, pictures and signs that may mislead the user or patient; point (a) of the same paragraph prohibits attributing to the device functions and properties which it does not have, point (b) creating a false impression regarding treatment or diagnosis, and point (ç) suggesting uses for the device other than those for which the conformity assessment was carried out.
Changing the intended purpose also has a cost. Article 16(1)(b) of the same Regulation states that the person who changes the intended purpose of a device already placed on the market or put into service will assume the obligations incumbent on manufacturers. Positioning a product by saying "we call this a device disinfectant" can move you into the position of manufacturer of that product.
Three typical borderline cases
The three product groups below make up almost the whole of the question, and the same test is applied to all three.
Instrument and device disinfectants: If the intended purpose is disinfection of medical devices, the result is inside the definition. Article 3(1)(eee)(3) of the Medical Device Regulation counts these products as medical devices; Section 7.3 of Annex VIII (Rule 16) determines their class. For this group an ÜTS registration comes into question.
Environment and surface disinfectants: If the intended purpose is disinfection of environmental surfaces such as floors, walls and furniture, the product is neither designed to be used on humans for a medical purpose nor specifically designed for disinfecting a device. If it corresponds to none of the sub-points of Article 3(1)(eee) of the Regulation, the product is not a medical device. If the label of the same product carries a statement such as "also used on surgical instruments", the picture changes; that statement is part of the intended purpose.
Hand antiseptics and skin applications: Here the decision depends on the purpose for which, and on which skin, the product is used. If the general hygiene purpose does not correspond to one of the medical purposes listed in Article 3(1)(eee)(1) of the Regulation, the product is not a medical device. Conversely, where the product achieves its principal effect by pharmacological, immunological or metabolic means, this is separately excluded in the same sub-paragraph; in that case the product falls outside the medical device definition for another reason.
In all three cases, the first documents to look at are the label and the instructions for use. A formulation document does not answer this question.
The biocidal side is run under a separate regulation and a separate authority
If you have concluded that your product is on the biocidal side, the process you will follow is not the subject of this page and does not run in ÜTS. Biocidal products are regulated by the Biocidal Products Regulation (Biyosidal Ürünler Yönetmeliği) published in the Official Gazette No. 27449 (4th bis) of 31/12/2009. The implementation of this legislation is carried out within the Ministry of Health by the General Directorate of Public Health (Halk Sağlığı Genel Müdürlüğü); the evaluation, authorisation and registration of biocidal products are duties of the relevant units of this General Directorate. Biocidal authorisation and licence procedures run on a product-type basis.
This page makes no reference to article-level provisions of the biocidal side, and this is deliberate. Writing a provision we cannot verify has the same result as making one up. For biocidal application requirements, you need to apply directly to the competent unit; our field of expertise and our service is medical device ÜTS registration consultancy.
The concrete consequences of registering on the wrong side
Drawing the boundary wrongly has a cost in two directions, and both either keep the product on the market or remove it from the market.
If the product is in fact a medical device but has not been treated as one, the whole chain is missing. Article 5(1) of the Medical Device Regulation states that only devices that meet the requirements of the Regulation may be placed on the market or put into service, and paragraph 2 states that a device shall meet the general safety and performance requirements set out in Annex I, taking into account its intended purpose. Article 20(1) of the same Regulation states that devices considered to conform to the requirements of the Regulation, other than custom-made or investigational devices, shall bear the CE marking of conformity, and paragraph 4 states that the CE marking shall be affixed before the device is placed on the market. On the commercial side, Article 26(2) of the Medical Device Sales, Advertising and Promotion Regulation (Tıbbi Cihaz Satış, Reklam ve Tanıtım Yönetmeliği) states that sales centres cannot sell devices that are not registered in the Agency's registration and information management system. A product that is a device but is not in ÜTS cannot be sold.
The reverse direction is also risky. Trying to register in ÜTS a product that does not fall within the device definition is contrary to the scope provision in Article 27(7)(dd)(5) of the Manual. Beyond that, Article 28/A(1) of the Sales, Advertising and Promotion Regulation states that if the Agency finds that applications have been made to its registration and information management systems with false information and documents, it may restrict the access of the persons or organisations carrying out those transactions to the relevant systems. An attempted registration in the wrong scope may not remain a problem only for that product.
The route to follow when a negative decision is issued
The Agency may conclude a device application negatively on grounds of scope. In this case the first reflex should not be to reapply. Article 40(9) of the Manual states that where the Agency issues a negative decision on one or more of the notifications within a device application and the firm considers this decision to be contrary to the legislation and the provisions of the Manual, before reapplying the firm may request reconsideration of the decision by using the "Report Request" screen ("Talep Bildir") in ÜTS, selecting "Medical Device Document and Product Registration Transactions" ("Tıbbi Cihaz Belge ve Ürün Kayıt İşlemleri") as the "Request Area" and entering the relevant Device Application Number in the "Medical Device/Document Application Number" field.
The same paragraph also binds the form of the request: the request must refer to the legislation and/or the Manual provisions relating to the matter objected to; requests in which the application number is not entered, or which contain no reference, are not taken into evaluation. Article 39(16) of the Manual sets up the same route for document applications. In a scope dispute, this reference is most often to the definition in Article 3 of the Regulation and to Section 7.3 of Annex VIII.
Which documents we look at to decide
A boundary decision is made not with an opinion but with documents, and the documents to look at are clear.
Label and instructions for use: This is the source of the intended purpose; Article 3(1)(hh) of the Medical Device Regulation ties the intended purpose to the manufacturer's declaration in these documents.
EU declaration of conformity: Article 11(2)(e) of the Manual requires the declaration to contain the intended purpose together with the information that allows the device to be identified and traced; point (g) of the same paragraph requires the risk class of the device and point (ı) requires, for declarations other than Class I Other and Class A, the identification of the notified body information and the EU certificate. If a disinfectant is Class IIa or IIb under Rule 16, the declaration must refer to a notified body.
Terminology match: Article 27(4)(b)(5) of the Manual requires consistency between the information in the description of the GMDN code to which the device is matched and the product characteristics. If no code can be found that describes the product, this is often an early sign that the product does not belong on the device side.
What we do when the boundary is unclear, and what we cannot do
Within medical device ÜTS registration consultancy, our concrete output on this subject is as follows:
Scope assessment: Using the product's label, instructions for use and manufacturer declaration, we assess in writing its position against points (eee) and (hh) of Article 3(1) of the Medical Device Regulation and prepare a reasoned note on whether the product falls within the device definition.
Classification reasoning: If the product is on the device side, we justify its class under Section 7.3 of Annex VIII (Rule 16) and write the reasoning into the application file.
Declaration consistency check: Before the application, we check whether the EU declaration of conformity is consistent with the product as regards intended purpose, risk class and notified body information, according to points (e), (g) and (ı) of Article 11(2) of the Manual.
Out-of-scope finding: If the product does not fall within the device definition, we say so clearly and make no registration attempt in ÜTS; Article 27(7)(dd)(5) of the Manual limits the scope of ÜTS to devices only.
Negative decision file: For a negative decision on grounds of scope, we prepare the "Report Request" ("Talep Bildir") text that meets the reference condition required by Article 40(9) of the Manual.
What we cannot do is particularly clear here. We do not carry out biocidal product licence or authorisation applications; this process is subject to a separate regulation and is run by a separate authority. We cannot make the final decision on which legislation a product is subject to; Article 4(1) of the Medical Device Regulation leaves this clarification route to the Agency. We cannot change or rewrite the intended purpose of the product on your behalf; Article 16(1)(b) of the same Regulation places manufacturer obligations on the person who changes the intended purpose. Nor can we put a claim in the application that is not on the label; Article 7(1) of the same Regulation prohibits this.
